Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease-Reference-Cited by-同舟云学术

Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease

Published:2002-10 Issue:10 Volume:13 Page:1628-1635
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Josting A.,Rudolph C.,Reiser M.,Mapara M.,Sieber M.,Kirchner H.H.,Dörken B.,Hossfeld D.K.,Diehl V.,Engert A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/10/1628/398952/mdf221.pdf

Reference31 articles.

1. Hodgkin disease: prognostic factors and treatment strategies;Josting;Curr Opin Oncol,2000

2. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin’s disease: results of a BNLI randomised trial;Linch;Lancet,1993

3. HDR-1: High-dose therapy (HDT) followed by hematopoietic stem cell transplantation (HSCT) for relapsed chemosensitive Hodgkin’s disease (HD): Final results of a randomized GHSG and EBMT trial (HD-R1);Schmitz;Proc Am Soc Clin Oncol,1999

4. Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin’s disease before intensive therapy and autologous bone marrow transplantation;Colwill;J Clin Oncol,1995

5. ESHAP is an active regimen for relapsing Hodgkin’s disease;Aparicio;Ann Oncol,1999

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced stage classic Hodgkin lymphoma (cHL): biology, clinical features, therapeutic approach, and management at relapse;Leukemia & Lymphoma;2024-09-03

2. Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges;Expert Review of Hematology;2024-06-27

3. Combining Brentuximab Vedotin With Dexamethasone, High-dose Cytarabine, and Cisplatin as Salvage Treatment in Pediatric Relapsed or Refractory Classic Hodgkin Lymphoma: Two Case Reports;Journal of Pediatric Hematology/Oncology;2024-06-24

4. What is the best salvage therapy for Hodgkin lymphoma?;Current Opinion in Oncology;2024-06-20

5. The role of autologous stem-cell transplantation in classical Hodgkin lymphoma in the modern era;Seminars in Hematology;2024-06